Van Creveldkliniek 60th anniversary scientific symposium: up-to-date in benign hematology

This anniversary scientific symposium will give an update of the current state of the art in benign hematology. We have a special guest from Japan, Midori Shima, a well-known hematologist from the Nara Medical University, who will discuss clinical development of emicizumab and its successor. In addition to hemophilia, our program will also include the latest developments in the care for patients with red blood cell disorders, platelet disorders and bone marrow failure. 
 
13.30
Welcome with coffee/tea      

14.00
Opening by chair 
Roger Schutgens 

14.15
The complexity of inherited bone marrow failure syndromes: what can we do?
Marije Bartels

14.50
New developments in red blood cell disorders: AI, synthetic data metabolomics and a new class of medication energizing the red cell
Ward van Beers

15.25
Latest developments in platelet disorders
Roger Schutgens

16.00
Coffee break

16.15
Development of emicizumab and its successor NXT007
Midori Shima

16.50
Physiotherapy care coordination for patients with bleeding disorders and its potential for other benign hematologic conditions
Merel Timmer

17.25
Modern hemophilia treatment: Balancing between prevention of bleeding and a life without restrictions
Kathelijn Fischer

18.00
Closing  
Roger Schutgens

---

Date:
Tuesday 3rd September 2024
Program starts at 14.00

Location:
Terrein De Wagenwerkplaats, “Het Oude Magazijn” 
Soesterweg 310F
3812 BH Amersfoort
Netherlands
(5 min walk from the train station)

Organization:
Van Creveldkliniek/ University Medical Center Utrecht 
Heidelberglaan 100, 3584 CX Utrecht
T. +31 (0)88 75 58 450
E. vck-secretariaat@umcutrecht.nl
www.vancreveldkliniek.nl

Registration:
Online registration fee € 50 per person

Accreditation:
Accreditation is requested at Dutch Society of Internal Medicine (NIV) and Dutch Association of Pediatrics (NVK).